211 related articles for article (PubMed ID: 26122284)
1. Ablation of B7-H3 but Not B7-H4 Results in Highly Increased Tumor Burden in a Murine Model of Spontaneous Prostate Cancer.
Kreymborg K; Haak S; Murali R; Wei J; Waitz R; Gasteiger G; Savage PA; van den Brink MR; Allison JP
Cancer Immunol Res; 2015 Aug; 3(8):849-54. PubMed ID: 26122284
[TBL] [Abstract][Full Text] [Related]
2. B7-H3 and B7-H4 expression in phyllodes tumors of the breast detected by RNA in situ hybridization and immunohistochemistry: Association with clinicopathological features and T-cell infiltration.
Kim GE; Kim NI; Park MH; Lee JS
Tumour Biol; 2018 Nov; 40(11):1010428318815032. PubMed ID: 30486739
[TBL] [Abstract][Full Text] [Related]
3. Expression and clinical significance of PD-L1, B7-H3, B7-H4 and TILs in human small cell lung Cancer (SCLC).
Carvajal-Hausdorf D; Altan M; Velcheti V; Gettinger SN; Herbst RS; Rimm DL; Schalper KA
J Immunother Cancer; 2019 Mar; 7(1):65. PubMed ID: 30850021
[TBL] [Abstract][Full Text] [Related]
4. B7-H3 Expression in NSCLC and Its Association with B7-H4, PD-L1 and Tumor-Infiltrating Lymphocytes.
Altan M; Pelekanou V; Schalper KA; Toki M; Gaule P; Syrigos K; Herbst RS; Rimm DL
Clin Cancer Res; 2017 Sep; 23(17):5202-5209. PubMed ID: 28539467
[No Abstract] [Full Text] [Related]
5. B7-H3 and B7-H4 Expression in Breast Cancer and Their Association with Clinicopathological Variables and T Cell Infiltration.
Kim NI; Park MH; Kweon SS; Lee JS
Pathobiology; 2020; 87(3):179-192. PubMed ID: 32088722
[TBL] [Abstract][Full Text] [Related]
6. High expression of B7-H3 on stromal cells defines tumor and stromal compartments in epithelial ovarian cancer and is associated with limited immune activation.
MacGregor HL; Sayad A; Elia A; Wang BX; Katz SR; Shaw PA; Clarke BA; Crome SQ; Robert-Tissot C; Bernardini MQ; Nguyen LT; Ohashi PS
J Immunother Cancer; 2019 Dec; 7(1):357. PubMed ID: 31892360
[TBL] [Abstract][Full Text] [Related]
7. Induced expression of B7-H4 on the surface of lung cancer cell by the tumor-associated macrophages: a potential mechanism of immune escape.
Chen C; Qu QX; Shen Y; Mu CY; Zhu YB; Zhang XG; Huang JA
Cancer Lett; 2012 Apr; 317(1):99-105. PubMed ID: 22108530
[TBL] [Abstract][Full Text] [Related]
8. Negative roles of B7-H3 and B7-H4 in the microenvironment of cervical cancer.
Han S; Wang Y; Shi X; Zong L; Liu L; Zhang J; Qian Q; Jin J; Ma Y; Cui B; Yang X; Kong B; Zhang Y
Exp Cell Res; 2018 Oct; 371(1):222-230. PubMed ID: 30099052
[TBL] [Abstract][Full Text] [Related]
9. Associations of B7-H3 and B7-H4 Expression in Ductal Carcinoma In Situ of the Breast With Clinicopathologic Features and T-Cell Infiltration.
Kim NI; Park MH; Lee JS
Appl Immunohistochem Mol Morphol; 2020; 28(10):767-775. PubMed ID: 31714284
[TBL] [Abstract][Full Text] [Related]
10. A review of B7-H3 and B7-H4 immune molecules and their role in ovarian cancer.
Fauci JM; Straughn JM; Ferrone S; Buchsbaum DJ
Gynecol Oncol; 2012 Nov; 127(2):420-5. PubMed ID: 22910694
[TBL] [Abstract][Full Text] [Related]
11. Assessment of combined expression of B7-H3 and B7-H4 as prognostic marker in esophageal cancer patients.
Chen L; Xie Q; Wang Z; Shi L; Wu C; Jiang J
Oncotarget; 2016 Nov; 7(47):77237-77243. PubMed ID: 27764786
[TBL] [Abstract][Full Text] [Related]
12. Roles of coinhibitory molecules B7-H3 and B7-H4 in esophageal squamous cell carcinoma.
Wang L; Cao NN; Wang S; Man HW; Li PF; Shan BE
Tumour Biol; 2016 Mar; 37(3):2961-71. PubMed ID: 26411671
[TBL] [Abstract][Full Text] [Related]
13. B7-H3, B7-H4, Foxp3 and IL-2 expression in cervical cancer: Associations with patient outcome and clinical significance.
Huang C; Zhou L; Chang X; Pang X; Zhang H; Zhang S
Oncol Rep; 2016 Apr; 35(4):2183-90. PubMed ID: 26848032
[TBL] [Abstract][Full Text] [Related]
14. The inhibitory role of b7-h4 in antitumor immunity: association with cancer progression and survival.
He C; Qiao H; Jiang H; Sun X
Clin Dev Immunol; 2011; 2011():695834. PubMed ID: 22013483
[TBL] [Abstract][Full Text] [Related]
15. Association of increased B7 protein expression by infiltrating immune cells with progression of gastric carcinogenesis.
Guo L; Liu Z; Zhang Y; Quan Q; Huang L; Xu Y; Cao L; Zhang X
Medicine (Baltimore); 2019 Feb; 98(8):e14663. PubMed ID: 30813210
[TBL] [Abstract][Full Text] [Related]
16. B7-H3 Promotes Prostate Cancer Progression in Mice by Antagonizing Myeloid-Derived Suppressor Cell Apoptosis.
Zhou Y; Zhang G; Zhang W; Wei X; Hou J; Huang Y
Technol Cancer Res Treat; 2020; 19():1533033820971649. PubMed ID: 33280506
[TBL] [Abstract][Full Text] [Related]
17. Aberrant expression of B7-H4 and B7-H5 contributes to the development of cutaneous squamous cell carcinoma.
Chen L; Zhou B; Tang M; Yao Y; Zhao Y; Hu Y; Lin Y; Ji J; Jiao Q
Arch Dermatol Res; 2024 Jun; 316(7):382. PubMed ID: 38850312
[TBL] [Abstract][Full Text] [Related]
18. Synergistic effects of host B7-H4 deficiency and gemcitabine treatment on tumor regression and anti-tumor T cell immunity in a mouse model.
Leung J; St-Onge P; Stagg J; Suh WK
Cancer Immunol Immunother; 2017 Apr; 66(4):491-502. PubMed ID: 28074226
[TBL] [Abstract][Full Text] [Related]
19. Co-deficiency of B7-H3 and B7-H4 identifies high CD8 + T cell infiltration and better prognosis in pancreatic cancer.
Si S; Wang L; Cao H; Xu Y; Zhan Q
BMC Cancer; 2022 Feb; 22(1):211. PubMed ID: 35219310
[TBL] [Abstract][Full Text] [Related]
20. Aberrant expression of B7-H4 correlates with poor prognosis and suppresses tumor-infiltration of CD8+ T lymphocytes in human cholangiocarcinoma.
Zhao X; Guo F; Li Z; Jiang P; Deng X; Tian F; Li X; Wang S
Oncol Rep; 2016 Jul; 36(1):419-27. PubMed ID: 27177355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
